Natural killer cell-based therapies. - Wikidata - wikimedia - TriplyDB

Natural killer cell-based therapies.

Natural killer cell-based therapies.

http://www.wikidata.org/entity/Q34988727

about

Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches Understanding of molecular mechanisms in natural killer cell therapy Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.Targeting natural killer cells and natural killer T cells in cancer.Frontline treatment of acute myeloid leukemia in adults.Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.Co-Activation of Cultured Human Natural Killer Cells: Enhanced Function and Decreased Inhibition.Autologous immune enhancement therapy in Philadelphia chromosome positive acute lymphoblastic leukemia.Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides.

P2860

Q26752518-E74F48A6-F619-4F92-98D5-E8F25ED7F551 Q28086976-65CE79EE-0E0B-4E52-BDE5-9B459500A872 Q35902972-828875E6-3FC1-4F83-A045-A2DDF22D5355 Q36529486-6EEA8012-FA72-445C-B9B6-4F81B5C1063D Q37299271-D6AAD7AF-A406-4130-B92A-72A6B31F4D5C Q37323344-9C72D1D0-95A7-4C82-97C9-803CCD44932D Q37535232-B567ED76-B5DE-49A1-A61D-23D5C8B26902 Q37995950-4C617EA5-D6B9-472F-8F95-054ADCB3E13A Q38767583-D7EBE069-E993-43A5-8D06-AD2490966A35 Q38838643-7D4C7E7A-8DC0-4AAD-AA61-1E1EC23A9F19 Q38930242-BB02B2E9-63D1-4E02-B4AB-706E2151180E Q39125118-9869A3B6-E81B-4BCE-97D5-BB3C4831DD02 Q41869977-A93184FE-BB9F-454E-B840-06B86D5F5D36 Q54108534-8722F563-91DB-45BA-BE7E-05B457F15C49

P2860

Natural killer cell-based therapies.

http://www.wikidata.org/entity/Q34988727

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Natural killer cell-based therapies.

@ast

Natural killer cell-based therapies.

@en

Natural killer cell-based therapies.

@nl

type

label

Natural killer cell-based therapies.

@ast

Natural killer cell-based therapies.

@en

Natural killer cell-based therapies.

@nl

prefLabel

Natural killer cell-based therapies.

@ast

Natural killer cell-based therapies.

@en

Natural killer cell-based therapies.

@nl

P1433

Q34988727-1E448F65-28C3-4B27-9666-30B6CD55B9DC

P1476

Q34988727-7B022CEA-F500-4011-85F2-113A0B2D73C1

P2093

Q34988727-46E62CB2-8D89-44A0-BBB6-3E8B6183591D

P2860

Q34988727-0006B34A-27B2-4F3B-82B7-3A2D4E6985B6

Q34988727-021B4AF6-B26A-4570-A977-4E95FBE07386

Q34988727-07ACBE75-5FF4-4A7C-A038-01C268C10C86

Q34988727-1152BFB9-C327-4B7D-99CC-69F4B7397D0D

Q34988727-12899EDC-F60E-4A82-91FB-4BE4A8306B5F

Q34988727-14625337-E58C-4793-890A-CDB9C8C8C220

Q34988727-1CD3F84B-25E0-4710-9898-7174D8C70B31

Q34988727-1EA97186-C4E2-4657-92AB-57C7F66F3C5F

Q34988727-20BDFF38-8457-4547-A069-A211BE1DD79C

Q34988727-446D1F78-BB7E-4813-9A06-08330AE73A05

P304

Q34988727-876DE4ED-B83A-4AE3-BD1B-A3A8BA45C4F7

P31

Q34988727-7D80ECE8-7235-413C-8C88-703C9800D173

P356

Q34988727-0DEA6391-F8B8-41B1-B5A3-0FE5256D7AF6

P478

Q34988727-BECE4A52-35B9-4DD1-9124-2B7E20B4618E

P50

Q34988727-EC547B70-0E18-49A0-B3B1-4C63836A420B

P577

Q34988727-E7F76DE7-14F7-464F-B23E-C1B8719B1E16

P5875

Q34988727-B15D0157-4432-4C44-B819-24956E46B1BE

P698

Q34988727-ED0C5F63-BEB2-4DF4-BC8F-2277B59FBDE8

P932

Q34988727-642CD17D-36E9-42BB-BA7E-1C549ADD0A3E

P356

P1433

F1000 medicine reports

P1476

Natural killer cell-based therapies.

@en

P2093

François Romagné

http://www.w3.org/2001/XMLSchema#string

P2860

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

Innate or adaptive immunity? The example of natural killer cells

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.

MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment.

Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3410/M3-9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51202986

http://www.w3.org/2001/XMLSchema#string

P698

21654924

http://www.w3.org/2001/XMLSchema#string

P932

3096881

http://www.w3.org/2001/XMLSchema#string